Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × Resectable Non-Small Cell Lung Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 316 Neoplasms 212 Carcinoma, Non-Small-Cell Lung 185 Prostatic Neoplasms 161 Colorectal Neoplasms 123 Neoplasm Metastasis 111 Pancreatic Neoplasms 108 Leukemia, Myeloid, Acute 108 Lung Neoplasms 105 Multiple Myeloma 100 Carcinoma, Hepatocellular 96 Lymphoma 90 Melanoma 81 Ovarian Neoplasms 78 Recurrence 77 Head and Neck Neoplasms 77 Brain Neoplasms 74 Leukemia 73 Leukemia, Lymphocytic, Chronic, B-Cell 70 Glioblastoma 66 Squamous Cell Carcinoma of Head and Neck 62 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Colonic Neoplasms 58 Lymphoma, Non-Hodgkin 56 Lymphoma, Follicular 54 Lymphoma, Large B-Cell, Diffuse 53 Rectal Neoplasms 48 Carcinoma, Renal Cell 48 Hematologic Neoplasms 47 Stomach Neoplasms 43

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡